Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Paul A. Christensen, Randall J. Olsen, View ORCID ProfileS. Wesley Long, Richard Snehal, James J. Davis, Matthew Ojeda Saavedra, Kristina Reppond, Madison N. Shyer, Jessica Cambric, Ryan Gadd, Rashi M. Thakur, Akanksha Batajoo, Regan Mangham, Sindy Pena, Trina Trinh, Jacob C. Kinskey, Guy Williams, Robert Olson, Jimmy Gollihar, James M. Musser
doi: https://doi.org/10.1101/2021.12.30.21268560
Paul A. Christensen
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
‡Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Randall J. Olsen
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
‡Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
S. Wesley Long
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
‡Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Richard Snehal
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
James J. Davis
¶Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois
**Computing, Environment and Life Sciences, Argonne National Laboratory, Lemont, Illinois
Matthew Ojeda Saavedra
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Kristina Reppond
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Madison N. Shyer
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Jessica Cambric
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Ryan Gadd
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Rashi M. Thakur
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Akanksha Batajoo
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Regan Mangham
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Sindy Pena
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Trina Trinh
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Jacob C. Kinskey
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Guy Williams
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Robert Olson
¶Consortium for Advanced Science and Engineering, University of Chicago, Chicago, Illinois
**Computing, Environment and Life Sciences, Argonne National Laboratory, Lemont, Illinois
Jimmy Gollihar
‡Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
James M. Musser
†Laboratory of Human Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
‡Laboratory of Antibody Discovery and Accelerated Protein Therapeutics, Center for Infectious Diseases, Houston Methodist Research Institute and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Genome data used in this study have been deposited to GISAID.
Posted January 01, 2022.
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Paul A. Christensen, Randall J. Olsen, S. Wesley Long, Richard Snehal, James J. Davis, Matthew Ojeda Saavedra, Kristina Reppond, Madison N. Shyer, Jessica Cambric, Ryan Gadd, Rashi M. Thakur, Akanksha Batajoo, Regan Mangham, Sindy Pena, Trina Trinh, Jacob C. Kinskey, Guy Williams, Robert Olson, Jimmy Gollihar, James M. Musser
medRxiv 2021.12.30.21268560; doi: https://doi.org/10.1101/2021.12.30.21268560
Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas
Paul A. Christensen, Randall J. Olsen, S. Wesley Long, Richard Snehal, James J. Davis, Matthew Ojeda Saavedra, Kristina Reppond, Madison N. Shyer, Jessica Cambric, Ryan Gadd, Rashi M. Thakur, Akanksha Batajoo, Regan Mangham, Sindy Pena, Trina Trinh, Jacob C. Kinskey, Guy Williams, Robert Olson, Jimmy Gollihar, James M. Musser
medRxiv 2021.12.30.21268560; doi: https://doi.org/10.1101/2021.12.30.21268560
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2652)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12242)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2664)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (852)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6537)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)